help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Osella, G.
Right arrow Articles by Terzolo, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Osella, G.
Right arrow Articles by Terzolo, M.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 2 604-607
Copyright © 2001 by The Endocrine Society


Original Studies

The Patients with Incidentally Discovered Adrenal Adenoma (Incidentaloma) Are Not at Increased Risk of Osteoporosis

G. Osella, G. Reimondo, P. Peretti, A. Alì, P. Paccotti, A. Angeli and M. Terzolo

Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, A. O. San Luigi, 10043 Orbassano, Torino, Italy

Address all correspondence and requests for reprints to: Giangia- como Osella, M.D., Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, A. O. San Luigi, Regione Gonzole 10, 10043 Orbassano, Torino, Italy. E-mail: g.osella{at}tiscalinet.it

The main problem in the management of the patients with incidentally discovered adrenal mass (incidentaloma) is whether and when the incidental mass puts the patient at increased risk for an adverse outcome. As osteoporosis is a well known complication of endogenous and exogenous glucocorticoid excess, it is likely that patients with incidentally discovered adrenocortical adenomas have impaired bone mass due to subclinical hypercortisolism. We measured spinal bone mineral density (BMD) by dual energy x-ray absorptiometry in 27 patients (9 men and 18 women) and 54 healthy subjects (18 men and 36 women) carefully matched for age, sex, body mass index, and menstrual status for a case-control analysis. BMD was also measured at the hip in the group of patients. A multiple regression analysis was performed to determine which biochemical variables might influence BMD values. Lumbar BMD values in patients with adrenal incidentaloma were not significantly different from those in control subjects (BMD, 0.926, 0.604–1.144 vs. 0.936, 0.645–1.268 g/cm2; P = NS). No significant difference in lumbar and femoral BMD was found between patients with or without subclinical Cushing’s syndrome. Among the variables processed, only PTH remained in the final model and was inversely correlated with lumbar spine and femoral neck BMD values (r = -0.5; r2 = 0.25; P = 0.015 and r = -0.42; r2 = 0.18; P = 0.03, respectively). In conclusion, our data do not suggest that the slight glucocorticoid excess associated with adrenal incidentaloma increases the risk of osteoporosis. The evaluation of BMD does not seem to be crucial in the management of incidentally discovered adrenal masses.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
I. Chiodini, G. Guglielmi, C. Battista, V. Carnevale, M. Torlontano, M. Cammisa, V. Trischitta, and A. Scillitani
Spinal Volumetric Bone Mineral Density and Vertebral Fractures in Female Patients with Adrenal Incidentalomas: The Effects of Subclinical Hypercortisolism and Gonadal Status
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2237 - 2241.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
G. Mansmann, J. Lau, E. Balk, M. Rothberg, Y. Miyachi, and S. R. Bornstein
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management
Endocr. Rev., April 1, 2004; 25(2): 309 - 340.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Chiodini, L. Tauchmanova, M. Torlontano, C. Battista, G. Guglielmi, M. Cammisa, A. Colao, V. Carnevale, R. Rossi, S. Di Lembo, et al.
Bone Involvement in Eugonadal Male Patients with Adrenal Incidentaloma and Subclinical Hypercortisolism
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5491 - 5494.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Tauchmanova, R. Rossi, B. Biondi, M. Pulcrano, V. Nuzzo, E.-A. Palmieri, S. Fazio, and G. Lombardi
Patients with Subclinical Cushing's Syndrome due to Adrenal Adenoma Have Increased Cardiovascular Risk
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4872 - 4878.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Chiodini, M. Torlontano, V. Carnevale, G. Guglielmi, M. Cammisa, V. Trischitta, and A. Scillitani
Bone Loss Rate in Adrenal Incidentalomas: A Longitudinal Study
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5337 - 5341.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society